Nationwide Fund Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-76,769
| Closed | -$1.56M | – | 2971 |
|
2017
Q3 | $1.56M | Buy |
76,769
+28,830
| +60% | +$585K | 0.01% | 1560 |
|
2017
Q2 | $772K | Sell |
47,939
-3,735
| -7% | -$60.1K | ﹤0.01% | 1936 |
|
2017
Q1 | $654K | Sell |
51,674
-3,577
| -6% | -$45.3K | ﹤0.01% | 2012 |
|
2016
Q4 | $732K | Buy |
55,251
+3,350
| +6% | +$44.4K | ﹤0.01% | 1953 |
|
2016
Q3 | $1.23M | Sell |
51,901
-400
| -0.8% | -$9.48K | 0.01% | 1647 |
|
2016
Q2 | $1.51M | Sell |
52,301
-4,620
| -8% | -$133K | 0.01% | 1504 |
|
2016
Q1 | $1.85M | Sell |
56,921
-753
| -1% | -$24.4K | 0.01% | 1387 |
|
2015
Q4 | $2.47M | Buy |
57,674
+793
| +1% | +$33.9K | 0.01% | 1263 |
|
2015
Q3 | $2M | Sell |
56,881
-3,794
| -6% | -$134K | 0.01% | 1360 |
|
2015
Q2 | $2.79M | Sell |
60,675
-13,253
| -18% | -$609K | 0.01% | 1260 |
|
2015
Q1 | $3.47M | Sell |
73,928
-7,418
| -9% | -$348K | 0.01% | 1164 |
|
2014
Q4 | $2.58M | Sell |
81,346
-11,998
| -13% | -$380K | 0.01% | 1283 |
|
2014
Q3 | $2.21M | Sell |
93,344
-15,730
| -14% | -$373K | 0.01% | 1384 |
|
2014
Q2 | $3.27M | Buy |
109,074
+34,888
| +47% | +$1.05M | 0.01% | 1216 |
|
2014
Q1 | $1.96M | Sell |
74,186
-123,893
| -63% | -$3.27M | 0.01% | 1362 |
|
2013
Q4 | $4.98M | Buy |
198,079
+3,339
| +2% | +$83.9K | 0.02% | 951 |
|
2013
Q3 | $3.99M | Buy |
194,740
+82,191
| +73% | +$1.69M | 0.02% | 1031 |
|
2013
Q2 | $2.25M | Buy |
+112,549
| New | +$2.25M | 0.01% | 1230 |
|